Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lisa X. Lee"'
Autor:
Nicolas Gonzalez, Jeffry Nahmias, Lisa X. Lee, Matthew Dolich, Michael Lekawa, Allen Kong, Areg Grigorian
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background Leukocytosis and thrombocytosis often follow splenectomy in blunt trauma patients, complicating the postoperative identification of infection. While the platelet count to white blood cell ratio provides diagnostic assistance to di
Externí odkaz:
https://doaj.org/article/250c09bfa72b46488171841fbe6bd634
Autor:
Shengwen Calvin Li, Lisa X Lee
Publikováno v:
World Journal of Stem Cells
The development of single-cell subclones, which can rapidly switch from dormant to dominant subclones, occur in the natural pathophysiology of multiple myeloma (MM) but is often "pressed" by the standard treatment of MM. These emerging subclones pres
Publikováno v:
Transfusion and Apheresis Science. :103656
Autor:
Lawrence Nguyen, Sami Souccar, Jonathan E. Zuckerman, Joline L. T. Chen, James Katrivesis, Nadine Abi-Jaoudeh, Lisa X Lee, Uttam Reddy, Afshan Baraghoush, Debra E. Morrison, Xiaodong Li, Beverly Wang, Wei Ling Lau
Publikováno v:
Journal of Nephropathology.
Native kidney biopsies are high-risk for bleeding complications due to the vascularity of the kidney and the inability to compress the biopsy site within a deep retroperitoneal location. Recommended parameters to minimize bleeding risk include a plat
Publikováno v:
The American Journal of Case Reports
Patient: Female, 57 Final Diagnosis: Renal heavy chain amyloidosis Symptoms: Fatigue • proteinuria Medication: — Clinical Procedure: Chemotherapy, consideration of autologous stem cell transplant Specialty: Hematology Objective: Rare disease Back
Autor:
Teresa Fogaren, Nauman S Siddiqui, Raymond L. Comenzo, Amandeep Godara, Cindy Varga, Denis Toskic, Lisa X. Lee
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(3)
Background Systemic AL amyloidosis (AL) is a rare disease in which clonal immunoglobulin light chains produced by monoclonal plasma cells circulate and misfold, resulting in direct toxicity and fibrillar deposition of amyloid in numerous tissues. Ear
Autor:
Denis Toskic, Cindy Varga, Melissa Warner, Teresa Fogaren, Raymond L. Comenzo, Lisa X. Lee, Adin Kugelmass, Ping Zhou
Publikováno v:
Blood. 132:1903-1903
INTRODUCTION : Currently patients with systemic AL amyloidosis (AL) are not identified until they are sick due to end-organ damage, usually a result of elevated clonal Ig free light chains (FLC) produced by λ clones in 75% of cases. Delays in diagno
Autor:
Lisa X. Lee, Yamin Li, Denis Toskic, Qiaobing Xu, Melissa Warner, Adin Kugelmass, Teresa Fogaren, Xun Ma, Liu Yang, Ping Zhou, Ming Wang, Raymond Comenzo
Publikováno v:
Blood. 132:3208-3208
INTRODUCTION : Despite advances in therapy, patients with relapsed AL amyloidosis die of resistant disease. New therapies are needed. siRNA directed at the constant regions of Ig light chains (LC) reduces LC mRNA and protein from patient cells, from
Autor:
Douglas A. Levine, Carol L. Brown, Dennis S. Chi, Robert A. Soslow, Ginger J. Gardner, Elizabeth E. Jewell, Richard Barakat, Mario M. Leitao, Guangming Han, Nadeem R. Abu-Rustum, Lisa X. Lee, Yukio Sonoda
Publikováno v:
Obstetrical & Gynecological Survey. 66:417-419
Objective The objective of the study was to identify additional factors that may improve the ability to predict underlying carcinoma risk in patients with complex atypical hyperplasia (CAH) of the uterus. Study Design All subjects diagnosed with CAH
Publikováno v:
Journal of Hematology & Oncology
The CD20-directed monoclonal antibody rituximab established a new era in lymphoma therapy. Since then other epitopes on the lymphoma surface have been identified as potential targets for monoclonal antibodies (mAb). While most mAbs eliminate lymphoma